World Wires · story 121870 · unverified · 1 source(s)

MaxCyte falls after $151.8M deal to buy Akron Bio for cash and stock

MaxCyte falls after $151.8M deal to buy Akron Bio for cash and stock

Open in the desk

Coverage

What this site indexes